Burzynski Research Institute, Inc. (BZYR)
OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0040 (-11.76%)
Feb 11, 2026, 9:30 AM EST
BZYR Market Cap
BZYR has a market cap or net worth of $3.94 million as of February 13, 2026. Its market cap has decreased by -48.28% in one year.
Market Cap
3.94M
Enterprise Value
3.94M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since April 28, 1997, BZYR's market cap has decreased from 16.41M to 3.94M, a decrease of -75.97%. That is a compound annual growth rate of -4.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.94M | 57.07% |
| Dec 29, 2025 | 2.51M | -38.39% |
| Dec 31, 2024 | 4.07M | -29.55% |
| Dec 29, 2023 | 5.78M | 70.28% |
| Dec 23, 2022 | 3.40M | 115.33% |
| Dec 31, 2021 | 1.58M | -33.33% |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LakeShore Biopharma | 6.63M |
| Brainstorm Cell Therapeutics | 5.96M |
| Orgenesis | 5.90M |
| GPL Holdings | 5.83M |
| Bioxytran | 5.30M |
| AXIM Biotechnologies | 4.99M |
| Enzon Pharmaceuticals | 4.79M |
| Nymox Pharmaceutical | 4.08M |